Microbial Therapeutic Products Market Brief Forecast and Analysis by Top Key Players to 2030

Future Market Insights’ (FMI) global microbial therapeutic products report provides an exhaustive yet unbiased analysis of future growth projections, taking into account the aforementioned developments to provide a bird’s eye view of the landscape. According to the study, demand for microbial therapeutic products is likely to grow at a steady clip, driven chiefly by growing incidence of antimicrobial resistance.

Over the years, the burden of antimicrobial resistance (AMR) has been escalating tremendously, besides prevalence of chronic conditions. The World Health Organization observes high resistance rates have been observed against antimicrobials used for treating urinary tract infections and certain types of diarrhea. For example, the rate of resistance to ciprofloxacin ranged anywhere between 8.4% and 93% across 33 countries. It is apprehended that this burden is compounding further due to the COVID-19 pandemic. Hence, efforts are underway to accelerate research for discovering breakthroughs in microbial therapeutics.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12891

Key Takeaways

  • By product, anti-cancer agents to capture nearly 30% revenue by 2020-end, owing to prolific research breakthroughs
  • By route of administration, injection pens to account for 2 out of 5 sales, attributed to patient hygiene concerns
  • By source, bacteria based microbial therapeutic products to remain preferred
  • Oncology to remain primary microbial therapeutic products application area, expanding at Y-o-Y rate exceeding 5% through 2020
  • Hospitals emerge as the primary microbial therapeutic end-users, attributed to availability of adequate infrastructure
  • North America to remain the market hegemon, East Asia to be fastest growing market

“Prominent manufacturers are seeking regulatory approvals to accelerate research and development operations for developing effective drug solutions to address the compounding antimicrobial resistance problems,” remarks the FMI analyst.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12891

COVID-19 Impact Analysis

The COVID-19 pandemic has adversely impact global economic outlook, with a prolonged recession on the cards across numerous industries. However, the microbial therapeutic products market has only stood to benefit from the pandemic crisis, as the global healthcare community accelerates efforts to find a potential cure for this deadly virus.

With inoculation procedures already being initiated across the U.K., it is only a matter of time before the anti-COVID-19 vaccine is available on a global scale. Despite this availability, healthcare providers will have a long road ahead with respect to discovering an orally administered drug formulation.

Therefore, governments are lending unconditional support to the global healthcare fraternity in terms of policy relaxation and disbursement of financial grants to aid in the research and development process, catapulting growth prospects.

Competitive Landscape

Prominent players operating in the global microbial therapeutic products market are emphasizing on acquiring regulatory approvals, forging partnerships and collaborations with competent authorities and biosimilars develop to capture substantial revenue shares across key regions.

Some reputed players operating within the global microbial therapeutic products landscape include Dr. Reddy’s Laboratories, Pfizer Inc., Sanofi SA, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Abbott Laboratories and Amgen Inc. to name a few.

In November 2020, Dr. Reddy’s Laboratories announced a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire its anti-allergy brands Momat Rino, Momat Rino Advance and Momat A to market them across Russia, Kazakhstan and Uzbekistan respectively.

In December 2020, Novo Nordisk announced the acquisition of Emisphere Technologies to exercise ownership of its Eligen SNAC oral delivery technology. The acquisition shall accelerate its GLP-1 receptor agonist seaglutide’s production on a larger scale.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-12891

More Valuable Insights on FMI’s Microbial Therapeutic Products Market

Future Market Insights, in its new report, offers an unbiased analysis of the global microbial therapeutic products market, analyzing historical demand from 2015-2019 and forecast statistics for 2020-2030. The study reveals growth projections on the microbial therapeutic products market on the basis of product (growth factors, anti-cancer agents, immunosuppressants, enzymes & others), route of administration (single use pre-filled injection/injection pen, multi-use injectors & others), source (bacteria & fungi), application (metabolic disorders, haematological disorders, oncology, immunological disorders, infectious diseases, allergic diseases & others) and end-user (hospitals, pharmaceuticals & biopharmaceutical companies and research & academic institutions) across seven prominent regions.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Canine Arthritis Treatment Market : The Trends Driving Growth And Shaping The Future 2029

A notable increase in dog ownership around the world, developing veterinary healthcare infrastructure and rising treatment options for canine arthritis are the key factors for the growth of the global canine arthritis treatment market.

As per the findings of Future Market Insights, the global canine arthritis treatment market is projected to experience significant growth during the forecast period, due to increasing prevalence of obesity induced arthritis among dogs and rise in awareness about the companion animal health. Moreover, ease in the FDA approval for novel and innovative canine arthritis treatment drugs will create growth opportunities for the market players.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/REP-GB-3552

The global canine arthritis treatment market valued in 2019 is estimated at ~ US$ 1.9 Bn, and is expected to increase at a CAGR of ~ 4% during the forecast period of 2019-2029.

Key Takeaways from Canine Arthritis Treatment Market Study

– Non-steroidal anti-inflammatory medications are referred as a first choice of veterinarian for the treatment of inflammation and pain. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling, and pain. Canines approved non-steroidal anti-inflammatory medications have demonstrated acceptable safety profile, which is in contrast to non-approved NSAIDs.
– Growth prospects of the canine arthritis market are relatively high in North America as compared to other regions, attributed to rise in the adoption rate of canines, increasing veterinary expenditure on their health, and greater awareness about the pet health.
– Market players remained focused on capitalizing on veterinary hospitals and clinics, as they provide an entire animal care and service support for better pet health.
– Oral formulations of major non-steroidal anti corticosteroids medications will continue to account for major share of the manufacturers’ bottom lines, in the view of increasing demand for their ease of administration and better animal compliance.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3552

Robust Clinical Development Pipeline to Dictate Stakeholders’ Strategies

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading players in the canine arthritis treatment market. These manufacturers continue to dominate the market landscape of canine arthritis treatment by ensuring product availability, collaborating with the local distributors, strengthening manufacturing facilities, and strategizing R&D for diversification of product portfolio.

What did Analysts Uncover during the Study?

A comprehensive view of the canine arthritis treatment market has led our analysts to conclude that, the market is growing at an impressive rate, with North America and Europe holding a large share of the global canine arthritis treatment market. Increase in the pet adoption rate in developed economies, increase in the disposable expense on the companion animals, and rise in awareness regarding pet health are anticipated to propel the market growth.

Read Full Report – https://www.futuremarketinsights.com/reports/canine-arthritis-market

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Infusion Pumps Market is likely to surge 5.4% CAGR from 2020-2030

FMI’s recent report on infusion pumps projects the market to surge at a CAGR of 5.4% from 2020-2030. Growth is attributed to increasing diabetic population across prominent regions. As per World Health Organization’s projections, there were 422 million diabetic people as of 2014, with a 5% increase in premature mortality.

Consequently, there has also been an increase in associated co-morbidities such as strokes, heart attacks, kidney failure and visual impairment. As a result, infusion pump usage has upticked in order to provide the appropriate medication and nutritional input.

To facilitate efficient drug delivery, manufacturers have incorporated various technological advancements in recent years. Additionally, the advent of wearable and smart infusion pumps is further fueling the market’s revenue prospects.

Global Infusion Pumps Market- Key Takeaways

  • Rising prevalence of cancer to push forward oncology-grade infusion pumps usage in the coming years
  • Ambulatory pumps are poised to hold major sway in the wake of swift drug and nutrient delivery
  • Europe to pivot global infusion pumps market growth, capturing over 1/3rd of the revenue pie
  • Global infusion pumps market is likely to surpass US$ 6 Bn by 2030-end
  • Favorable business reimbursement policies are expected to bolster infusion pumps demand in coming years

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-859

COVID-19 Impact Analysis

The COVID-19 pandemic is anticipated to have a moderate impact on the global infusion pumps market. In the initial months of the pandemic’s onset, a slump in the demand-supply equation was observed. This was in response to the imposition of lockdowns and social distancing protocols. Eventually, a resurgence was recorded.

In recent months, regulatory authorities such as the U.S Food and Drug Administration (FDA) issued emergency use authorization to increase the availability of infusion pumps and related accessories. Infusion pumps have been pivotal in administering vital medicines and parenteral nutrition to patients admitted for chronic ailments.

As hospitals reach a saturation point, governments are providing flexibility to infusion pump manufacturers to address supply shortages by permitting them to resume operations. This is slated to sustain the infusion pumps market demand in the short-term forecast.

Global Infusion Pumps Market- Competitive Intelligence

Prominent players 

  • Fresenius Kabi AG,
  • Terumo Corporation,
  • Medtronic Plc,
  • Baxter International Plc.,
  • Smith Medical,
  • MOOG Inc.,
  • Johnson & Johnson Services Inc.,
  • ICU Medical Inc. and
  • Becton Dickinson & Company among others.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-859

Product launches, expansions, collaborations and other inorganic strategies are being pursued by the aforementioned players. In 2019, Terumo Corporation announced the launch of its TERUFUSION Infusion Pump Type LM Series which utilize smart cutting-edge IT solutions to deliver optimal management and prevents inadvertent excess infusion of drugs into the patient.

In 2010, Hospira Inc. partnered with Smith Medical to market and promote various infusion pumps. The companies collaborated in order to co-promote Hospira’s Symbiq and Plum A+ general infusion pumps along with its Hospira MedNet safety software. The venture also promoted Smith Medical’s Medfusion syringe pumps with the PharmGuard Medication Safety Software.

More Insights on the Infusion Pumps Market Report

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report incorporates an unbiased analysis of the following segments: product type (syringe pumps, ambulatory pumps, volumetric pumps, implantable pumps, insulin pumps, enteral pumps, PCA pumps and pump accessories), application (chemotherapy/oncology, pediatrics/neonatology, analgesia, gastroenterology, hematology and diabetes), end-user (hospitals, ambulatory surgical centers, homecare, clinics and others) and region (North America, Latin America, Europe, MEA, East Asia, South Asia and Oceania).

Infusion Pumps Market – Key Segment

Product Type

  • Syringe Pumps
  • Ambulatory Pumps
  • Volumetric Pumps (Peristaltic and Cassette/Piston)
  • Implantable Pumps
  • Insulin Pumps
  • Enteral Pumps
  • PCA Pumps
  • Pump Accessories

Application

  • Chemotherapy/Oncology
  • Pediatrics/Neonatology
  • Analgesia
  • Gastroenterology
  • Hematology
  • Diabetes

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-859

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare
  • Clinics
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Middle East & Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Laboratory Information Systems (LIS) Market Foreseen To Grow Exponentially Over 2030

Global laboratory information system (LIS) market revenues are set to grow at 10.1% CAGR through 2030, according to an updated edition by Future Market Insights (FMI). The 2020-2030 version of the report builds upon the widely cited previous version, and incorporates the latest developments, notably, the impact of COVID-19 pandemic on this market.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-875

Over the years, the healthcare industry has witnessed massive technological advancements in the form of automation, big data analytics and cloud computing. The most important aspect in the industry is the need to reconcile administrative operations with caregiving operations. This has become possible through the introduction of advanced laboratory testing systems.

Laboratories are the foundational stone for primary healthcare administration. It is the laboratories which are the site for drug development and API formulations. To accelerate the effectiveness of these functions, there is a need to streamline mundane operations such as data collation, assimilation and record maintenance.

The need for systematic data documentation to reduce paperwork is primarily driving the laboratory information systems market. Significant adoption has been witnessed since the COVID-19 pandemic’s onset, enabling healthcare providers to concentrate on drug and vaccine development by smoothening data collection procedures.

Key Findings

  • Europe & North America will remain lucrative, accounting for 4/5th of the revenue pie
  • Cloud-based laboratory information systems to register maximum increase during the forecast period
  • Vendors are increasingly capitalizing on developing LIS software for various healthcare verticals
  • Hospital-grade laboratory information systems are gaining significant momentum

COVID-19 Impact Analysis

Clinical laboratories are finding it unnerving to cope with the rapid influx of COVID-19 testing samples, impacting their ability to provide accurate testing. Incorporation of automated solutions is therefore anticipated to relieve these clinics of this uncertainty by promoting efficient testing of voluminous samples.

Prominent players in the laboratory information systems landscape are collaborating with public and private sector organizations to employ advanced technologies for implementing COVID-19 testing capabilities. For instance, LabWare Technologies has collaborated with the National Health Service to provide laboratory management software to healthcare settings across the United Kingdom.

Thus, the market shall witness a significant upsurge during the short-term forecast period, with an increasing number of healthcare providers accelerating the uptake of technologically advanced laboratory information systems.

“Manufacturers are increasing their presence across emerging markets and forging effective distribution networks with regional players. This is helping them expand their outreach and broaden their customer base,” opines the FMI analyst.

Competitive Intelligence

The global laboratory information systems market is highly fragmented, characterized by the presence of over 50 vendors. Prominent players include: Cerner Corp., Evident, McKesson, Medical Information Technology (MEDITECH), Epic Systems Corporation, SCC Soft Computer, Roper Technologies Inc., CompuGroup Medical and LabWare.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-875

With regard to product launches, Cerner Corporation launched CommunityWorks Foundations, a tailor-made cloud-based technology platform for rural and critical access hospitals in July 2020. This technology shall prove instrumental in reducing overhead costs and reducing lengthy implementation procedures. The platform enables hospitals to maintain electronic health records, reducing immense amount of paperwork.

Recently, in August 2020, Medical Information Technology (MEDITECH) partnered with TECHNATION Health in Canada. This collaboration is aimed at enhancing the privacy and security framework of healthcare providers across the nation, ensuring better patient data security. The solution involves provision of cybersecurity and data sovereignty among other objectives.

Tinnitus Management Market at a CAGR of around 2.8% over the forecast period (2021-2031)

According to a recent study by Future Market Insights (FMI), the global tinnitus management market is expected to register sustainable growth during the forecast period. The market size is likely to grow from US$ 2.5 Bn in 2021 to over US$ 3.2 Bn by 2031 at a CAGR of around 2.8% over the forecast period (2021-2031).

Rising prevalence of tinnitus, technological advancements in tinnitus management devices, and rise in research and development activities undertaken by key manufacturers are some of the factors driving the tinnitus management market.

Tinnitus is the medical terminology for a buzzing or ringing noise in the ears. Most people refer to tinnitus as “ringing in the ears.” Tinnitus can either be subjective or objective. Objective tinnitus is uncommon. Subjective tinnitus is very common, accounting for maximum sales of tinnitus management devices and drugs worldwide.

Tinnitus is the third most common health concern among the people throughout the globe. About 10%–15% of adults have prolonged tinnitus requiring medical evaluation worldwide. This increasing prevalence of tinnitus will propel the growth of tinnitus management market over the forecast period.

Manufacturers are increasingly focusing on quality, technological, and aesthetic features when developing devices such as invisible devices, cloud integration, Ai integration, and drugs with lowest possible side-effects. This is expected to have a positive impact on the global market.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6114

Key Takeaways from Tinnitus Management Study

  • By product, devices hold the maximum share of 93.8% in 2021, expanding at 2.9% CAGR during the forecast period.
  • By indication, subjective tinnitus will account for 95.6% of the market share in 2021 exhibiting the highest demand.
  • By distribution channel, audiology centers & ENT clinics together account for more than 60% of the market share in 2021.
  • By region, North America held the largest share of 52.7% of the global tinnitus management market in 2021.

“Technological improvements in tinnitus management devices will remain a priority for the market players. Apart from focus on innovations, market players are expected to aim at strategic collaborations to gain expertise and expand their product portfolio,” says the FMI Analyst.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-6114

Who is Winning?

The key market players covered by FMI include Signia, Starkey Hearing Technologies, Inc., GN Hearing A/S, Widex A/S, Oticon Inc., Neuromod Devices Ltd., Neuromonics Inc., Puretone, Inc., Pfizer Inc., Sanofi and GlaxoSmithKline.

Some of the leading manufacturers of tinnitus management market are focusing on product launch, collaboration, and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

  • In October 2020, Starkey and OrCam partner to provide groundbreaking assistive technology to hearing and visually impaired people.
  • In March 2019, Sivantos Pte. Ltd., and Widex A/S, announced the successful completion of the business combination between Sivantos and Widex. The newly created company will operate under the name WS Audiology and be headquartered in Lynge, Denmark and Singapore.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-6114

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Skincare Market to grow an 8.1% CAGR through 2021-2031.

Increase In awareness regarding advanced skincare products and rising prevalence of chronic diseases are expected to drive skincare market. According to a study by Future Market Insights (FMI), the global skincare market is forecast to reach a valuation of US$ 8,823.4 Mn in 2021.

Skincare products such as skin cleansers, hand sanitizer, skin conditioners, and surgical scrubs are increasingly used to maintain skin hygiene and to prevent the spread of infections. The rising prevalence of chronic diseases and increase in demand for hand sanitizers amid COVID-19 pandemic is expected to boost the growth of the skincare market.

Moreover, increasing incidence of hospital-acquired diseases such as surgical site infection (SSI) is creating opportunities for growth. Sales will surge further as a result of the increasing awareness about advanced skincare products. Social media & innovative online campaigns aimed at creating awareness are therefore reshaping the skincare market.

Increasing market consolidation activities, adoption of strategic agreements among the leading manufacturers and increasing research activities aimed at launching effective products are some of the factors enabling growth. Some of the leading players are aiming to strengthen their product portfolio by launching a various online campaign. For instance, in 2021, Galderma Laboratories, L.P.-Cetaphil launched an innovative digital campaign to connect with millions of consumers experiencing skin sensitivity.with the market expected to exhibit a CAGR of 8.1% during the forecast period (2021-2031)

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13122

Key Takeaways from Skincare Market Study

  • Skincare market is expected to rise at 8.1% CAGR between 2021 and 2031
  • High willingness among consumers to spend on personal health and hygiene will drive growth in the U.S., which will account for over 85% of sales in North America by 2031
  • The U.K. will remain a key market for skincare products within Europe. Rising demand from various hospitals, healthcare, and critical care centers will continue supporting growth
  • Expansion of the healthcare sector will push growth in Germany, which will account for maximum skincare products sales within Europe’s healthcare sector
  • Strong growth is likely in China, as consumers increasingly focus on hygiene and sanitization to prevent the risk of infection

“Rising Prevalence of Surgical-site infections and infective diseases and growing demand for hand sanitizers are driving the growth of global skincare market. Key players trying to partner with R&D Companies, patent licensees & holders, reputable manufacturers, prestigious universities, government agencies worldwide to develop and commercializing novel products based on pioneered and patented technologies,” said a lead FMI analyst.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13122

Who is Winning?

The leading manufacturers are focusing on research and development to develop effective and compatible skincare products that can meet the end-use demand. The current pandemic outbreaks and the growing demand for hand sanitizing product have led manufacturers to ramp up their research efforts to expand their product portfolio.

Besides this, several key players are focusing on market consolidation activities such as a merger, acquisition, supply distribution partnerships, and launching new products. This is leading to high competitiveness in the market. Key manufacturers are also keen to expand the market footprint.

For instance, in 2020, GOJO has expanded its product portfolio to increases sales of PURELL sanitizer, wipes, soap and surface spray by establishing a new manufacturing facility in Maple Heights and Navarre, Ohio.

Some of the market players covered by FMI include are 3M Company, Cardinal Health, Inc., Ecolab, Whiteley Corporation, Reckitt Benckiser Group PLC, Carrollclean, Johnson & Johnson Consumer Inc., Galderma Laboratories, L.P., PDI, Inc., Betco Corporation, Pal International, PSK Pharma Pvt. Ltd., Metrex Research, LLC., Gojo Industries, Inc., Unilever, Steris Plc, Procter & Gamble and among others consolidating their positions through mergers, acquisitions and new product launches.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-13122

Want more insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global skincare market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the skincare market on basis of product such as Skin Cleansers, Hand Sanitizers, Surgical Scrubs, Skin Conditioner and Other. Based on form the skincare market is segmented as Liquid, Gel & Lotions, Wipes and Spray & Foams. Based on end-users such as Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Reference Laboratories, Rehabilitation Centers, Long Term Care Centers, Critical Care Centers, Pharmaceutical & Biotechnology Companies, Academics and Research Institutes and Homecare Settings across seven major regions.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Wet Wipes Market are expected to cross US$ 8.0 Bn by 2031

According to a recent study by Future Market Insights (FMI), the sales of wet wipes are expected to top US$ 3.7 Bn in 2021, growing at a CAGR of over 7.6% during the forecast period (2021-2031).

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13751

Increasing health-care related issues and the rising prevalence of infectious diseases and skin-related problems have increased concerns among general population. As a result, awareness with regards to the adoption of personal care and hygiene practices is at all time high.

Regular usage of sanitizer, wet wipes, and tissues for cleanliness and maintaining proper hygiene has positively affected the wet wipes market. With various wet wipes options available in the market, catering to diverse purposes such as incontinence wet wipes- for urinary incontinence, sterile wound cleansing wet wipe- for cleaning wounds, and skin care wet wipe- for regular use; growth prospects for future remains optimistic.

Traditionally, products such as soap, face wash, cleansing milk, and others which are already available in the market have been in use for personal hygiene for generations. But factors such as easy handling, convenience while travelling, achieving cleanliness of hand and face without using water have buoyed consumer inclination in favor of wet wipes.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13751

Companies specializing in wet wipes have been focusing on developing more innovative products such as fragrance- filled wet wipes, environment-friendly, and biodegradable wet wipes and using wood pulp and cotton to avoid harmful effect on sensitive skin.

Government as well as private companies are involved in specialized marketing campaigns to address the need for wet wipes. Furthermore, mergers, acquisitions and collaboration are undertaken by companies to increase the product portfolio as well as reach. All these factors are expected to create demand for wet wipes.

Key takeaways from Wet wipes Market study

  • By product, incontinence wipes constitute the most lucrative segment in terms of revenue. The demand for incontinence wipes is expected to increase at a CAGR of over 7% 2021-2031.
  • By disposability, non-flushable wipes segment will hold a revenue share of around 75% in 2021 and is expected to follow the similar growth trend in the future.
  • By application, skin care wipes segment holds the largest share and will continue to dominate this segment in the forecast period.
  • In terms of end user, hospitals are leading the market and are expected to gain more than 25% of revenue share over the forecast period.
  • North America will dominate the global wet wipes market in terms of revenue in 2021, followed by Europe region.
  • India is dominating the South Asia wet wipes market, accounting for nearly 29% of global market share in 2021.
  • China holds leading position in East Asia and is expected to account for nearly 40% of market share.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-13751

“Steered by changing consumer preference, market players are rethinking sources of materials used for wet wipes manufacturing. Their focus is shifting towards more sustainable and biodegradable options to reduce the burden of wet wipes disposal on the environment. This will present attractive opportunities for growth of the market in the near future,” said a lead FMI analyst.

Who is winning?

Some of the leading manufacturers of wet wipes are focusing on innovative product launches, specialized marketing campaigns, mergers, acquisitions and partnership strategies, thereby enhancing their market presence.

  • In February 2018, Procter & Gamble Co. announced the acquisition of Snowberry, a New Zealand-based skincare company which specialized in natural ingredient products.
  • In August 2020, Kimberly-Clark’s brand Pull-Ups launched a product, New Leaf™. Pull-Ups® New Leaf™ is made with plant-based ingredients like sugarcane and fluff pulp, carefully selected and crafted to provide the high level of protection.
  • In February 2018, Stryker completed the acquisition of Entellus Medical, a medical technology company and strengthen Stryker’s personal care product portfolio.

The key market players covered by FMI include Essity Aktiebolag (publ), Kimberly-Clark, Procter & Gamble, Cardinal Health, Medtronic, Stryker, Coloplast, Hindustan Unilever Ltd., Medline Industries Inc., ConvaTec Inc., The Himalaya Drug Company, Domtar Corporation, Johnson & Johnson Private Limited, Hollister Incorporated and Godrej Consumer Products Limited.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Pre-mature Baby Monitoring Equipment Market Companies Analysis, Advancement And Precise Outlook 2028

Premature births have become very common. Premature babies also called preemies require extra care than the full-term babies. Premature birth occurs due to infections, stress, chromosomal abnormalities, maternal age, and chromosomal abnormalities. Premature babies have weak immune system and underdeveloped parts that include the skin, lungs and digestive system. Technology advanced devices have been developed, which monitor the heart rate, respiratory rate, blood pressure, and temperature of the premature baby. More efforts are being put up by the manufacturers in order to develop equipment that function efficiently.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-6961

Also, equipment such as wireless camera system has been developed by the manufacturers, which remains contactless with the premature babies and detects their movement nonstop. It detects even the slight changes in the skin colour, heart beats, and movements of its shoulders. Moreover if the baby does not suffer from any problem and has a normal heart & breathing rate the baby is given Kangaroo care. This is a technique where the baby is held skin to skin contact with the mother for an extended time which provides the baby the apt temperature (warmth if the baby is cold and vice versa), protects from infection, increase weight gain and provides safety and affection. These equipment and techniques can save a lot of pre-mature babies from dying.

Factors Driving the Growth of Premature Baby Monitoring Equipment Market

The demand for premature baby monitoring equipment has increased due to increasing number of deaths of premature babies. According to GE health care, over 15 million pre-mature babies are born worldwide every year and more than 1 million children die. Rise in the demand for the equipment and cases of premature occurrences are driving the growth of the market. Moreover, enhancement in the healthcare infrastructure is also playing a vital role in the growth of the market. The companies are providing technically advanced and efficient products which provide oxygen, maintain temperature, monitor the heartbeats and protects from cold temperatures.

Increasing birth rate in developing countries such as Asia pacific is driving the demand for premature baby monitoring equipment with the rising awareness. Moreover, the demand for premature baby monitoring equipment is going to rise globally with the rise in the population in countries such as India and China, which account for highest birth rates. Also, increasing prevalence of infections acquired in the hospitals in premature babies is further challenging the growth of the market. However, decreasing birth-rates in developed countries and poor approach towards the premature babies in the developing countries can restrict the growth of the market. Increasing investment and R&D will overcome the deficiencies for better alternatives for the growth for the premature baby monitoring equipment market.

Regional Market Outlook

Geographically, the global premature baby monitoring equipment market is segmented into seven key regions, namely North America, South America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan, Japan and Middle East & Africa. North America followed by Europe is the dominant market of premature baby monitoring equipment due to technological advancement, infrastructure and better health care facilities. On the other hand, Asia pacific is expected to grow during the forecast period due to the rise in the birth rates and increasing government initiatives. The government is creating awareness programs for providing better healthcare facilities for the children by increasing public expenditures. Moreover the manufacturers are investing on the premature baby monitoring equipment due to huge demand by the end users.

Key Participants

Examples of some of the key players in the global premature baby monitoring equipment market are Analogic Corporation, GE Healthcare, Koninklijke Philips N.V.; Medtronic plc; CooperSurgical, Inc.; Stryker, Olympus Corporation, Drägerwerk AG & Co. KGaA,, Novamed USA, Weyer, Fisher & Paykel Healthcare, BabyBloom Healthcare, Novos Medical Systems, etc.

Key Data Points Covered in Report

The report covers exhaustive analysis on:

  • The Premature baby monitoring equipment market by composition, product type, end user and region
  • Regional level market analysis of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, Middle East & Africa by test type, end-use segments and country
  • Premature baby monitoring equipment market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Premature baby monitoring equipment market Size & Forecast 2018 – 2026
  • Premature baby monitoring equipment market Current Trends/Issues/Challenges
  • Competition & Companies involved

Market Segmentation

By product type

  • Blood Pressure Monitor
  • Cardiac Monitors
  • Pulse Oximeters
  • Capnsographs
  • Integrated Monitoring Devices

By End User

  • Hospitals
  • Paediatric and Neonatal Clinics
  • Nursing Homes

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-6961

Report Highlights:

  • Shifting industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size, recent industry trends
  • Key competition landscape, market structure, regulatory scenario
  • Epidemiology outlook for diseases
  • Economical spending, regional healthcare outlook, consumer healthcare expenditure
  • Availability of procedure, cost of stents, specificity and sensitivity of test
  • Strategies for key players and product offerings, channel strategies, regional foot print, channel footprint
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance in terms of value and volume

Orthopaedic Prosthetics Market Size, Status And Global Outlook 2020 To 2030

As per Future Market Insights (FMI) – an ESOMAR-certified market research firm, global orthopaedic prosthetics market will be worth US$ 3.22 Bn by 2030.

Orthopaedic prosthetics have been witnessing personalized breakthrough innovations since the last few years. The market is witnessing customized prosthetics that enable modifications on the basis of functionality and anatomy of the respective patient.

According to FMI, tailored orthopaedic prosthetics, an outcome of 3D imaging software, is available in various lengths and sizes. This innovation is likely to drive the orthopaedic prosthetics market during the forecast period.

The market is expected to witness a paradigm shift. Emphasis is being laid on consumer-friendly products, so as to simplify the lives of amputees”, says an FMI analyst.

Reconstructing or amputating of lower limb proves to be challenging for both – practitioners as well as patients as it largely depends on the affected limb’s viability and characteristics.

Get Report Sample @  https://www.futuremarketinsights.com/reports/sample/rep-gb-1443

However, advances with respect to orthopaedic prostheses have paved the way for loads of options to be considered while choosing between limb amputation and reconstruction.

As such, the well-fitting prostheses avert the rest of the soft tissue’s breakdown by redistribution of compressive force at the time of weight bearing, thereby minimizing force on skin. This convenience holds the flag for lower extremity orthopaedic prosthetics high in the forecast period.

As far as technology is concerned, digitally empowered devices are the future of orthopaedic prosthetics market. Along with anticipating patients’ actions (through the use of AI), these devices enable remote monitoring.

Digitally powered orthopaedic prosthetics are all set to revolutionize the market at present and also in the forecast period.

Also, as mentioned above, personalization of products gets a simplified approach with digitization, as traceability becomes easy. Also, 3D imaging helps the patient visualize the placement of limbs well in advance, thereby voicing his/her choice with regards to implants.

Though North America and Europe account for leading revenue share, opportunities in Asia Pacific are growing. The countries like India, China, Thailand, Saudi Arabia are on the verge of increasing the contribution of their GDP towards healthcare.

As Asia Pacific is home to majority of those suffering from diabetic ailments, the orthopaedic prosthetics market set to catch up herein. On the other hand, the consistency shown by North America and Europe could be attributed to increasing incidences of peripheral vascular diseases concerned with limbs coupled with injuries related to sports.

Want More Insights?

Orthopaedic Prosthetics Market, a new study from Future Market Insights, opines on the evolution of the orthopaedic prosthetics market from 2014 – 2018 and presents demand projections from 2020 – 2030 on the basis of; product (upper extremity prosthetics, lower extremity prosthetics, sockets, liners and modular components), technology (conventional, hybrid orthopaedic prosthetics and electric powered orthopaedic prosthetics) and end user (prosthetic clinics, hospitals, rehabilitation centre and others) across seven prominent regions.

Any Questions About Report, Speak to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1443

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Prescription Delivery Services Market Detailed Analysis Of Current And Future Industry Figures Till 2020-2030

Prescription delivery services are an integral part of healthcare. With the global population’s life expectancy increasing, incidence of chronic and infectious ailments is also rising. As a consequence, expenditure on medicines and treatment is surging across all countries. While traditional retailing has prevailed, recent innovations have paved the way for several novel approaches.
Timely drug delivery is the cornerstone of an effective healthcare infrastructure. Rising prevalence of chronic and infectious ailments have accelerated production of prescription drugs, prompting vendors to develop effective distribution networks.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12534

Advancements in consumer touch points and supply chains, including e-commerce, convenience stores and retail stores have greatly altered the prescription delivery services landscape. Advancements such as drone-based delivery and tracker based prescriptions are helping usher in smooth customer experience.
Furthermore, advanced prescription delivery systems have not only assisted in providing round-the-clock customer services but also helped manage dosage, therapy adherence and provide feedback to clinicians.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12534

Prescription Delivery Services Market- Key Takeaways

  • Diabetic prescription drugs to hold major sway, poised to capture 36.7% market share by 2030
  • Ease of access to drugs addressing chronic conditions is slated to drive retail pharmacy growth to greater heights
  • North America to expand stupendously at a CAGR of 18.4% from 2020-2030, attributed to the presence of multiple convenience and pharmacy stores
  • Global prescription delivery services market to reach US$ 434.3 Mn by 2030-end

“Adoption of self-checkout kiosks and medicine dispensing machines shall enhance medicine purchasing experience of customers, permitting vendors to experience greater customer loyalty,” concludes the FMI analyst.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-12534

COVID-19 Impact Insights
The COVID-19 pandemic has generated fertile ground for the prescription delivery services market. The imposition of nationwide lockdowns to enforce social distancing have reduced footfalls across conventional pharmacies. This has compelled patients to rely on online retail platforms to avail their medicines.
Furthermore, heightened vulnerability of geriatrics suffering from co-morbidities to the coronavirus has necessitated stockpiling of essential medicines, thus keeping the need for prescription delivery services afloat throughout the pandemic’s duration. This panic buying behavior shall usher in an 80% y-o-y growth.
Growth is especially anticipated to be robust across the U.S, China and India, countries with the highest rates of infections. Collectively accounting for 40% of the global infection rate, these countries have witnessed an unprecedented increase in hoarding prescription medicines by individual households. This shall continue until the latter-half of 2021.

Market Witnessing Entry of e-Commerce Players
The Prescription Delivery Service Market is witnessing entry of e-Commerce, pharmacy and retail chains, albeit at a local or regional level. Technological developments, new product launches and collaborations characterize some critical expansion strategies of market players.

Some of the key players in the Prescription Delivery Service Market are: Walgreens Co., Walmart Stores Inc., CVS Health, Giant Eagle Inc., Express Scripts Holding Company, Ali Health and Kroger Co. to name a few.
Besides these established players, several startup companies are also emerging as potential game changers in the industry. These include NetMeds, Kfyao, Capsule, Myra Medicines, NURX, MedAvail, Zipdrug, Insightfil and ScriptDrop to name a few.

Walgreens, a prominent retail pharmaceutical distributor, has a robust presence in the global prescription delivery services market. The company offers refills, auto refills, drug information and home delivery services.
In 2017, the company acquired Rite Aid for a sum of US$ 5.2 billion, resulting in the merger of two of the United States’ three largest pharmacy chains.